Qiagen NV | QIA - Net Income


Qiagen NV reported $107.83M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Akebia Therapeutics USD -12.24M 12.78M Dec/2025
Alaunos Therapeutics USD -1.01M 153K Mar/2026
argenx SE USD 366M 166.95M Mar/2026
Avita Medical AUD -11.62M 1.7M Dec/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Ionis Pharmaceuticals USD -93M 136M Mar/2026
IQVIA Holdings USD 274M 240M Mar/2026
Moderna USD -1.34B 517M Mar/2026
Organon & Co USD -205M 365M Dec/2025
Qiagen NV USD 107.83M 22.21M Dec/2025
Revvity USD 40.72M 57.65M Mar/2026
Tectonic Therapeutic USD -19.23M 186K Dec/2025
Viatris USD 176.4M 516.5M Mar/2026
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025